These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [TBL] [Abstract][Full Text] [Related]
9. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators. Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430 [TBL] [Abstract][Full Text] [Related]
10. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial. Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074 [TBL] [Abstract][Full Text] [Related]
11. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Grimm W; Plachta E; Maisch B Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513 [TBL] [Abstract][Full Text] [Related]
12. Impact of device programming on the success of the first anti-tachycardia pacing therapy: An anonymized large-scale study. Shakibfar S; Krause O; Lund-Andersen C; Strycko F; Moll J; Osman Andersen T; Høgh Petersen H; Hastrup Svendsen J; Igel C PLoS One; 2019; 14(8):e0219533. PubMed ID: 31393871 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of anti-tachycardia pacing for terminating fast ventricular tachycardia in Japanese implantable cardioverter defibrillator patients. Primary results of the SATISFACTION study. Watanabe T; Inoue K; Kashiwase K; Mine T; Hirooka K; Shutta R; Okuyama Y; Mizuno H; Shimoshige S; Takenaka S; Sumiyoshi T; Yambe Y; Shirota K; Nitta J; Ito M; Keida T; Nanto S Circ J; 2014; 78(11):2643-50. PubMed ID: 25262963 [TBL] [Abstract][Full Text] [Related]
14. The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators. Tuan TC; Lo MT; Lin YJ; Hsieh WH; Lin C; Huang NE; Lo LW; Chao TF; Liao JN; Hsieh YC; Wu TJ; Chen SA J Cardiovasc Electrophysiol; 2014 Apr; 25(4):411-417. PubMed ID: 24320556 [TBL] [Abstract][Full Text] [Related]
15. [Long-term efficacy of antitachycardia pacing for treatment of ventricular tachycardia in patients with implantable cardioverter/defibrillator]. Fiek M; Hoffmann E; Dorwarth U; Müller D; Steinbeck G Z Kardiol; 1999 Oct; 88(10):815-22. PubMed ID: 10552185 [TBL] [Abstract][Full Text] [Related]
16. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks. Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474 [TBL] [Abstract][Full Text] [Related]
17. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial. Saeed M; Neason CG; Razavi M; Chandiramani S; Alonso J; Natarajan S; Ip JH; Peress DF; Ramadas S; Massumi A J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1349-54. PubMed ID: 20561107 [TBL] [Abstract][Full Text] [Related]
18. Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing. Bennett MT; Leader N; Sapp J; Parkash R; Gardner M; Healey JS; Thibault B; Sterns L; Essebag V; Birnie D; Sivakumaran S; Nery P; Andrade JG; Krahn AD; Tang A Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005921. PubMed ID: 29618476 [TBL] [Abstract][Full Text] [Related]
19. Differences in ventricular tachyarrythmias and antitachycardia pacing effectiveness according to the ICD indication (primary versus secondary prevention): an analysis based on the stored electrograms. Jiménez-Candil J; Hernández J; Martín A; Moríñigo J; Perdiguero P; Bravo L; Ruiz S; Sánchez PL J Interv Card Electrophysiol; 2015 Nov; 44(2):187-95. PubMed ID: 26306456 [TBL] [Abstract][Full Text] [Related]
20. Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients. Boulé S; Brigadeau F; Marquié C; Salleron J; Klug D; Kouakam C; Guédon-Moreau L; Duhamel A; Acheré C; Wissocque L; Lacroix D; Kacet S Pacing Clin Electrophysiol; 2012 Oct; 35(10):1209-16. PubMed ID: 22817404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]